GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SHOX2 | hg19_v2_chr3_-_157824292_157824334 | -0.40 | 9.7e-10 | Click! |
HOXC5 | hg19_v2_chr12_+_54426637_54426637 | -0.07 | 2.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89292422 Show fit | 31.06 |
ENST00000495489.1
|
immunoglobulin kappa variable 1-8 |
|
chr6_-_32557610 Show fit | 30.36 |
ENST00000360004.5
|
major histocompatibility complex, class II, DR beta 1 |
|
chr2_+_90108504 Show fit | 29.71 |
ENST00000390271.2
|
immunoglobulin kappa variable 6D-41 (non-functional) |
|
chr2_+_90077680 Show fit | 29.35 |
ENST00000390270.2
|
immunoglobulin kappa variable 3D-20 |
|
chr1_-_153518270 Show fit | 24.44 |
ENST00000354332.4
ENST00000368716.4 |
S100 calcium binding protein A4 |
|
chr2_-_89385283 Show fit | 23.93 |
ENST00000390252.2
|
immunoglobulin kappa variable 3-15 |
|
chr2_-_89340242 Show fit | 23.52 |
ENST00000480492.1
|
immunoglobulin kappa variable 1-12 |
|
chr2_+_90198535 Show fit | 23.50 |
ENST00000390276.2
|
immunoglobulin kappa variable 1D-12 |
|
chr2_-_89247338 Show fit | 22.63 |
ENST00000496168.1
|
immunoglobulin kappa variable 1-5 |
|
chr11_+_35201826 Show fit | 22.53 |
ENST00000531873.1
|
CD44 molecule (Indian blood group) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 332.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.0 | 161.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 56.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.0 | 45.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
8.4 | 42.2 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
5.6 | 39.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 33.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.9 | 30.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
3.4 | 30.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
6.9 | 27.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 133.6 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 80.8 | GO:0072562 | blood microparticle(GO:0072562) |
1.3 | 66.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
9.3 | 55.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
2.1 | 42.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 41.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 39.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
5.6 | 39.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 34.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 34.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 503.8 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 69.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
4.2 | 58.2 | GO:0050700 | CARD domain binding(GO:0050700) |
1.1 | 49.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.0 | 37.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
3.4 | 26.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 26.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
1.2 | 24.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 22.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 22.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 62.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.9 | 43.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.2 | 32.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 30.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.8 | 22.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 21.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 20.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 15.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 14.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 11.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 67.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.6 | 61.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
1.3 | 47.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 41.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 39.8 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
1.5 | 33.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 33.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.2 | 23.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 21.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 20.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |